Clinical management of borderline tumours of the ovary - experience from the "Berlin Online Tumour Conference For Gynaecological Malignancies"

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1701-1706

  Sehouli, Jalid ^a   Oskay Oezcelik, Guelten ^a   Pietzner, Klaus ^a   Chen, Frank ^a   Coumbos, Alexandra ^b   Darb Esfahani, Silvia ^a   Schuback, Beatrix ^c   Heinrich, Georg ^c   Kronenberger, Christel ^d   Lorsbach, Michael ^e   Lichtenegger, Werner ^a   Chekerov, Radoslav ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Outpatient Practice of Gynecological Oncology   (Germany)

^c Auguste Viktoria Hospital ^*  (Germany)

^d Vivantes Auguste Viktoria Klinikum   (Germany)

^e ALCEDIS GMBH   (Germany)

Author keywords

Borderline ovarian tumour; Clinical management; Tumour board

Indexed keywords

BORDERLINE OVARIAN TUMOR; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CONFERENCE PAPER; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; OVARY TUMOR; PATIENT CARE; PRIORITY JOURNAL; SYSTEMIC THERAPY;

ADULT; AGED; BERLIN; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; MIDDLE AGED; OVARY; PROGNOSIS; TREATMENT OUTCOME;

EID: 77954584180     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Denkert C and Dietel M: Borderline tumors of the ovary and peritoneal implants. Verh Dtsch Ges Pathol 89: 84-91, 2005.
2. Sehouli J, Denkert C, Dietl M and Lichtenegger W: Management von Borderlinetumoren des Ovars (BOT). Management of borderline ovarian tumours. Onkologe Der 11: 1127-1138, 2005. (Pubitemid 43074848)
3. Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B and Ben-Baruch G: Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 97: 780-783, 2005. (Pubitemid 40824646)
4. Hart WR: Borderline epithelial tumors of the ovary. Mod Pathol 18: S33-50, 2005.
5. Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, Yamada H, Yaegashi N, Okamura K, Izutsu T, Sugiyama T, Tanaka T, Kurachi H, Sato A, Tase T and Mizunuma H: Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer 94: 1586-1591, 2006.
6. Skirnisdottir I, Garmo H, Wilander E and Holmberg L: Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 123: 1897-1901, 2008.
7. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S and Beller U: Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95: S161-192, 2006.
8. Wong HF, Low JJ, Chua Y, Busmanis I, Tay EH and Ho TH: Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004: Int J Gynecol Cancer 17: 342-349, 2007.
9. Sherman ME, Berman J, Birrer MJ, Cho KR, Ellenson LH, Gorstein F and Seidman JD: Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol 35: 961-970, 2004. (Pubitemid 39037179)
10. Cohen L and Fishman DA: Ultrasound and ovarian cancer. Cancer Treat Res 107: 119-132, 2002.
11. Schrecengost A: Ovarian mass - benign or malignant? Aorn J 76: 792-802, 2002.
12. Engelen MJ, de Bruijn HW, Hollema H, Hoor KA, Willemse PH, Aalders JG and van der Zee AG: Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol 78: 16-20, 2000. (Pubitemid 30439472)
13. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL and Hendrickson MR: Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol 29: 707-723, 2005.
14. Rollins SE, Young RH and Bell DA: Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol 30: 457-462, 2006.
15. Silva EG, Gershenson DM, Malpica A and Deavers M: The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol 30: 1367-1371, 2006. (Pubitemid 44655469)
16. Chang SJ, Ryu HS, Chang KH, Yoo SC and Yoon JH: Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 87: 476-481, 2008.
17. Cadron I, Leunen K, Van Gorp T, Amant F, Neven P and Vergote I: Management of borderline ovarian neoplasms. J Clin Oncol 25: 2928-2937, 2007.
18. Schmalfeldt B and Pfisterer J: Interdisziplinäre S2k-Leitlinie für die Diagnostik und Therapie maligner Ovarialtumoren. In: e.V. KOdAGO (ed.). Muenchen W. Zuckschwerdt Verlag, 2007.
19. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E and Malvasi A: Conservative surgery for borderline ovarian tumors: A review. Gynecol Oncol 100: 185-191, 2006. (Pubitemid 41815071)
20. Jones MB: Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol 49: 517-525, 2006. (Pubitemid 44181424)
21. Du Bois A, Pfisterer J, Kellermann L and Kreienberg R: Treatment of Advanced Ovarian Cancer in Germany: The Impact of Participation in Clinical Trials. Geburtsh Frauenheilk, pp. 863-871, 2001. (Pubitemid 34027055)
22. Du Bois A, Rochon J, Lamparter C and Pfisterer J: Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 15: 183-191, 2005. (Pubitemid 40396951)
23. Chekerov R, Denkert C, Boehmer D, Suesse A, Widing A, Ruhmland B, Giese A, Mustea A, Lichtenegger W and Sehouli J: Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany. Int J Gynecol Cancer 18(1): 1-7, 2008.
24. Santoso JT, Schwertner B, Coleman RL and Hannigan EV: Tumor board in gynecologic oncology. Int J Gynecol Cancer 14: 206-209, 2004.
25. Horning SJ and Mellstedt H: Introduction: ASCO-ESMO consensus statement on quality cancer care. Ann Oncol 17: 1061, 2006.
26. Kurzgefasste Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. (Informationszentrum für Standards in der Onkologie (ISTO) (ed.), 2008.
27. Coleman RL: Objective: To evaluate the impact of a weekly gynecologic oncology (GO) tumor board (TB) on patient care and graduate education. Proc Am Soc Clin Oncol 22: Abstr. 1981, 2003.
28. Henson DE, Frelick RW, Ford LG, Smart CR, Winchester D, Mettlin C and Yates JW: Results of a national survey of characteristics of hospital tumor conferences. Surg Gynecol Obstet 170: 1-6, 1990. (Pubitemid 20048048)
29. Lichtenegger W, Sehouli J, Buchmann E, Karajanev C and Weidemann H: Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC). J Obstet Gynaecol Res 24: 447-451, 1998.
30. Trope CG, Kristensen G and Makar A: Surgery for borderline tumor of the ovary. Semin Surg Oncol 19: 69-75, 2000.
31. Poncelet C, Fauvet R, Boccara J and Darai E: Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study. Ann Surg Oncol 13: 565-571, 2006.
32. Cusido M, Balaguero L, Hernandez G, Falcon O, Rodriguez-Escudero FJ, Vargas JA, Vidart JA, Zamora L, Monera M and Alonso A: Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol 104: 617-622, 2007. (Pubitemid 46240250)
33. Suh-Burgmann E: Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103: 841-847, 2006.
34. Yinon Y, Beiner ME, Gotlieb WH, Korach Y, Perri T and Ben-Baruch G: Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil Steril 88: 479-484, 2007. (Pubitemid 47212145)
35. Marcickiewicz J and Brannstrom M: Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence. Acta Obstet Gynecol Scand 85: 1496-1500, 2006. (Pubitemid 44863770)
36. Boran N, Cil AP, Tulunay G, Ozturkoglu E, Koc S, Bulbul D and Kose MF: Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 97: 845-851, 2005. (Pubitemid 40824656)
37. Tinelli FG, Tinelli R, La Grotta F, Tinelli A, Cicinelli E and Schonauer MM: Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol Scand 86: 81-87, 2007. (Pubitemid 46009531)
38. Maltaris T, Koelbl H, Seufert R, Kiesewetter F, Beckmann MW, Mueller A and Dittrich R: Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 8: 515-533, 2006. (Pubitemid 44263423)
39. Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C and Darai E: Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 100: 1145-1151, 2004. (Pubitemid 38325941)
40. Kumpulainen S, Kuoppala T, Leminen A, Komulainen M, Puistola U, Sankila R, Makinen J and Grenman S: Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstet Gynecol Scand 86: 610-614, 2007. (Pubitemid 46676319)
41. Fader AN and Rose PG: Role of surgery in ovarian carcinoma. J Clin Oncol 25: 2873-2883, 2007.
42. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK and Tornos C: Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 82: 1096-1103, 1998. (Pubitemid 28136523)
43. Seidman JD, Sherman ME and Kurman RJ: Recurrent serous borderline tumors of the ovary. Int J Gynecol Pathol 17: 387-389, 1998.
44. Sutton GP, Bundy BN, Omura GA, Yordan EL, Beecham JB and Bonfiglio T: Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (Gynecologic Oncology Group study). Gynecol Oncol 41: 230-233, 1991.
45. Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M and Tornos C: Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 83: 2157-2163, 1998. (Pubitemid 28525397)